Relationship between maximum clot firmness in ROTEM® and postoperative bleeding after coronary artery bypass graft surgery in patients using clopidogrel

Annals of Cardiac Anaesthesia

Volumn 21, Issue 2, 2018, Pages 175-180

  Azarfarin, Rasoul ^a   Noohi, Fereidoon ^b   Kiavar, Majid ^b   Totonchi, Ziae ^a   Heidarpour, Avaz ^a   Hendiani, Amir ^c   Koleini, Zahra Sadat ^c   Rahimi, Saeid ^c  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bleeding; clopidogrel; coronary artery bypass grafting; thromboelastometry

Indexed keywords

CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; AORTIC CLAMPING; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING RISK; BLOOD CLOTTING PARAMETERS; BLOOD EXAMINATION; BLOOD TRANSFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM CLOT FIRMNESS; MIDDLE AGED; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; RISK; RISK ASSESSMENT; ROTATIONAL THROMBOELASTOMETRY; THORAX DRAINAGE; ADOLESCENT; AGED; ANALOGS AND DERIVATIVES; BLOOD; BLOOD CLOTTING; EMERGENCY HEALTH SERVICE; POSTOPERATIVE COMPLICATION; PROCEDURES; PROSPECTIVE STUDY; REOPERATION; STATISTICS AND NUMERICAL DATA; THROMBOELASTOGRAPHY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; CORONARY ARTERY BYPASS; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REOPERATION; THROMBELASTOGRAPHY; TICLOPIDINE; YOUNG ADULT;

EID: 85045677017     PISSN: 09719784     EISSN: 09745181     Source Type: Journal    
DOI: 10.4103/aca.ACA_139_17     Document Type: Article

References (36)

1. Eisenberg MJ, Filion KB, Azoulay A, Brox AC, Haider S, Pilote L, et al. Outcomes and cost of coronary artery bypass graft surgery in the United States and Canada. Arch Intern Med 2005;165:1506-13.
2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-181.
3. Cannon CP, Mehta SR, Aranki SF. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery. Ann Thorac Surg 2005;80:768-79.
4. Michelson EL, Morganroth J, Torosian M, Mac Vaugh H 3rd. Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 1978;76:694-7.
5. Kam PC, Nethery CM. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia 2003;58:28-35.
6. Müller C, Büttner HJ, Petersen J, Roskamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000;101:590-3.
7. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
8. Ascione R, Ghosh A, Rogers CA, Cohen A, Monk C, Angelini GD, et al. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: A word of caution. Ann Thorac Surg 2005;79:1210-6.
9. Filsoufi F, Rahmanian PB, Castillo JG, Kahn RA, Fischer G, Adams DH, et al. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements. J Cardiothorac Vasc Anesth 2008;22:60-6.
10. Kapetanakis EI, Medlam DA, Boyce SW, Haile E, Hill PC, Dullum MK, et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist's panacea or the surgeon's headache? Eur Heart J 2005;26:576-83.
11. Ray JG, Deniz S, Olivieri A, Pollex E, Vermeulen MJ, Alexander KS, et al. Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel. BMC Cardiovasc Disord 2003;3:3.
12. Chu MW, Wilson SR, Novick RJ, Stitt LW, Quantz MA. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004;78:1536-41.
13. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: The clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial. Circulation 2004;110:1202-8.
14. Jarvis B, Simpson K. Clopidogrel: A review of its use in the prevention of atherothrombosis. Drugs 2000;60:347-77.
15. Mishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 1999;34:1884-90.
16. Weber AA, Braun M, Hohlfeld T, Schwippert B, Tschöpe D, Schrör K, et al. Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. Br J Clin Pharmacol 2001;52:333-6.
17. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: A report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2011;124:e652-735.
18. Whitten CW, Greilich PE. Thromboelastography: Past, present, and future. Anesthesiology 2000;92:1223-5.
19. Shore-Lesserson L. Evidence based coagulation monitors: Heparin monitoring, thromboelastography, and platelet function. Semin Cardiothorac Vasc Anesth 2005;9:41-52.
20. Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993;7:410-5.
21. Wasowicz M, McCluskey SA, Wijeysundera DN, Yau TM, Meinri M, Beattie WS, et al. The incremental value of thrombelastography for prediction of excessive blood loss after cardiac surgery: An observational study. Anesth Analg 2010;111:331-8.
22. Woźniak S, Woźniak K, Hryniewiecki T, Kruk M, Rózański J, Kuśmierczyk M, et al. The predictive value of multiple electrode platelet aggregometry for postoperative bleeding complications in patients undergoing coronary artery bypass graft surgery. Kardiochir Torakochirurgia Pol 2016;13:3-9.
23. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001;29:2271-5.
24. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive summary: A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Catheter Cardiovasc Interv 2012;79:453-95.
25. Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA, et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: The ACUITY (Acute catheterization and urgent intervention triage strategY) trial. J Am Coll Cardiol 2009;53:1965-72.
26. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 2010;304:1559-67.
27. Harty JA, McKenna P, Moloney D, D'Souza L, Masterson E. Anti-platelet agents and surgical delay in elderly patients with hip fractures. J Orthop Surg (Hong Kong) 2007;15:270-2.
28. Mehta RH, Roe MT, Mulgund J, Ohman EM, Cannon CP, Gibler WB, et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 2006;48:281-6.
29. Preisman S, Kogan A, Itzkovsky K, Leikin G, Raanani E. Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg 2010;37:1367-74.
30. Chowdhury M, Shore-Lesserson L, Mais AM, Leyvi G. Thromboelastograph with platelet mapping (TM) predicts postoperative chest tube drainage in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2014;28:217-23.
31. Mahla E, Suarez TA, Bliden KP, Rehak P, Metzler H, Sequeira AJ, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: The timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012;5:261-9.
32. Kasivisvanathan R, Abbassi-Ghadi N, Kumar S, Mackenzie H, Thompson K, James K, et al. Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery. Br J Surg 2014;101:1383-90.
33. Görlinger K, Jambor C, Dirkmann D, Dusse F, Hanke A, Adamzik M, et al. Platelet function analysis with point-of-care methods. Herz 2008;33:297-305.
34. Serraino GF, Murphy GJ. Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: Updated systematic review and meta-analysis. Br J Anaesth 2017;118:823-33.
35. Bhardwaj V, Kapoor PM. Platelet aggregometry interpretation using ROTEM-PART-II. Ann Card Anaesth 2016;19:584-6.
36. Gorlinger K, Bhardwaj V, Kapoor PM. Simulation in coagulation testing using rotational thromboelastometry: A fast emerging, reliable point of care technique. Ann Card Anaesth 2016;19:516-20.